Cato to license Merges etrials software

Mary Stevens | | Health Imaging | Artificial Intelligence
Cato Research has signed a five-year technology transfer agreement to use Merge Healthcare’s etrials EDC [electronic data capture] technology to build and deploy custom clinical trial studies.

The technology transfer program allows Cato to use the etrials EDC system to deploy custom clinical trial studies that leverage the reporting capabilities of Merge’s technology. The etrials EDC solution is built on a software-as-a-service platform, and can be licensed on a subscription or study basis, according to Milwaukee-based Merge. In addition, Merge’s etrials IVR and ePRO software can be integrated with the EDC system to provide eClinical solutions.

Merge will also provide training and support to Cato, headquartered near Research Triangle Park, N.C.

Mary Stevens

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.